Ajanta Pharma Ltd. — Call Transcript 2026

May 8, 2026

ajanta pharma

Ajanta Pharma Limited
Ajanta Tower, 54-A, M Vasanji
Road, Chakala, Andheri (E),
Mumbai 400 093, India

T +91 22 6060 9000
E legal.info@ajantapharma.com
W www.ajantapharma.com

Great Place to Work Certified THE BEST FOR YOU

$8^{\text{th}}$ May 2026

BSE LIMITED Phiroze Jeejeebhoy Towers Dalal Street, Mumbai – 400001	National Stock Exchange of India, Exchange Plaza, 5^{th} Floor, Plot no. C/1, G Block, Bandra Kurla Complex, Bandra (East), Mumbai – 400 051
Scrip Code: BSE – AJANTPHARM 532331	Scrip Code: NSE AJANTPHARM EQ

Sub: Written transcript of Earnings call conducted on 5^th May 2026

Dear Sir / Madam,

Further to our communication dated 5^th May 2026 on earnings call, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, written transcript of the earnings call held on 5^th May 2026 at 4.30 p.m. has been uploaded on the Company’s website and can be accessed through the link

https://www.ajantapharma.com/assets/frontend/images/investors/files/quarterly_results/1778236394_Earnings-Call-Transcript-Q4-(Jan-Mar)-2025-26.pdf

This is for your information and records please.

Yours faithfully,

GAURANG
CHINUBHAI
SHAH

Digitally signed by
GAURANG CHINUBHAI
ShAH
Date: 2026.05.08
14:27:24 +00'00'

GAURANG SHAH
Sr. VP – Legal & Company Secretary

Corporate Identity Number - L24230MH1979PLC022059